List of Chapters/Sections(Table Of Content)
1 Introduction to Research & Analysis Reports
1.1 Psychedelic Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Psychedelic Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Psychedelic Medicine Overall Market Size
2.1 Global Psychedelic Medicine Market Size: 2021 VS 2028
2.2 Global Psychedelic Medicine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Psychedelic Medicine Players in Global Market
3.2 Top Global Psychedelic Medicine Companies Ranked by Revenue
3.3 Global Psychedelic Medicine Revenue by Companies
3.4 Top 3 and Top 5 Psychedelic Medicine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Psychedelic Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Psychedelic Medicine Players in Global Market
3.6.1 List of Global Tier 1 Psychedelic Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Psychedelic Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Psychedelic Medicine Market Size Markets, 2021 & 2028
4.1.2 Psilocybin
4.1.3 LSD
4.1.4 MDMA
4.1.5 DMT
4.1.6 Ketamine
4.1.7 Others
4.2 By Type - Global Psychedelic Medicine Revenue & Forecasts
4.2.1 By Type - Global Psychedelic Medicine Revenue, 2017-2022
4.2.2 By Type - Global Psychedelic Medicine Revenue, 2023-2028
4.2.3 By Type - Global Psychedelic Medicine Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Psychedelic Medicine Market Size, 2021 & 2028
5.1.2 Depressive Disorders
5.1.3 Post-Traumatic Stress Disorders
5.1.4 Substance Abuse Disorders
5.1.5 Obsessive Compulsive Disorders
5.1.6 Others
5.2 By Application - Global Psychedelic Medicine Revenue & Forecasts
5.2.1 By Application - Global Psychedelic Medicine Revenue, 2017-2022
5.2.2 By Application - Global Psychedelic Medicine Revenue, 2023-2028
5.2.3 By Application - Global Psychedelic Medicine Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Psychedelic Medicine Market Size, 2021 & 2028
6.2 By Region - Global Psychedelic Medicine Revenue & Forecasts
6.2.1 By Region - Global Psychedelic Medicine Revenue, 2017-2022
6.2.2 By Region - Global Psychedelic Medicine Revenue, 2023-2028
6.2.3 By Region - Global Psychedelic Medicine Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Psychedelic Medicine Revenue, 2017-2028
6.3.2 US Psychedelic Medicine Market Size, 2017-2028
6.3.3 Canada Psychedelic Medicine Market Size, 2017-2028
6.3.4 Mexico Psychedelic Medicine Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Psychedelic Medicine Revenue, 2017-2028
6.4.2 Germany Psychedelic Medicine Market Size, 2017-2028
6.4.3 France Psychedelic Medicine Market Size, 2017-2028
6.4.4 U.K. Psychedelic Medicine Market Size, 2017-2028
6.4.5 Italy Psychedelic Medicine Market Size, 2017-2028
6.4.6 Russia Psychedelic Medicine Market Size, 2017-2028
6.4.7 Nordic Countries Psychedelic Medicine Market Size, 2017-2028
6.4.8 Benelux Psychedelic Medicine Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Psychedelic Medicine Revenue, 2017-2028
6.5.2 China Psychedelic Medicine Market Size, 2017-2028
6.5.3 Japan Psychedelic Medicine Market Size, 2017-2028
6.5.4 South Korea Psychedelic Medicine Market Size, 2017-2028
6.5.5 Southeast Asia Psychedelic Medicine Market Size, 2017-2028
6.5.6 India Psychedelic Medicine Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Psychedelic Medicine Revenue, 2017-2028
6.6.2 Brazil Psychedelic Medicine Market Size, 2017-2028
6.6.3 Argentina Psychedelic Medicine Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Psychedelic Medicine Revenue, 2017-2028
6.7.2 Turkey Psychedelic Medicine Market Size, 2017-2028
6.7.3 Israel Psychedelic Medicine Market Size, 2017-2028
6.7.4 Saudi Arabia Psychedelic Medicine Market Size, 2017-2028
6.7.5 UAE Psychedelic Medicine Market Size, 2017-2028
7 Players Profiles
7.1 COMPASS Pathways PLC
7.1.1 COMPASS Pathways PLC Corporate Summary
7.1.2 COMPASS Pathways PLC Business Overview
7.1.3 COMPASS Pathways PLC Psychedelic Medicine Major Product Offerings
7.1.4 COMPASS Pathways PLC Psychedelic Medicine Revenue in Global Market (2017-2022)
7.1.5 COMPASS Pathways PLC Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Psychedelic Medicine Major Product Offerings
7.2.4 Pfizer Psychedelic Medicine Revenue in Global Market (2017-2022)
7.2.5 Pfizer Key News
7.3 Eli Lilly
7.3.1 Eli Lilly Corporate Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Psychedelic Medicine Major Product Offerings
7.3.4 Eli Lilly Psychedelic Medicine Revenue in Global Market (2017-2022)
7.3.5 Eli Lilly Key News
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Corporate Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Psychedelic Medicine Major Product Offerings
7.4.4 GlaxoSmithKline Psychedelic Medicine Revenue in Global Market (2017-2022)
7.4.5 GlaxoSmithKline Key News
7.5 Cybin Inc
7.5.1 Cybin Inc Corporate Summary
7.5.2 Cybin Inc Business Overview
7.5.3 Cybin Inc Psychedelic Medicine Major Product Offerings
7.5.4 Cybin Inc Psychedelic Medicine Revenue in Global Market (2017-2022)
7.5.5 Cybin Inc Key News
7.6 Field Trip Health
7.6.1 Field Trip Health Corporate Summary
7.6.2 Field Trip Health Business Overview
7.6.3 Field Trip Health Psychedelic Medicine Major Product Offerings
7.6.4 Field Trip Health Psychedelic Medicine Revenue in Global Market (2017-2022)
7.6.5 Field Trip Health Key News
7.7 ATAI Life Sciences
7.7.1 ATAI Life Sciences Corporate Summary
7.7.2 ATAI Life Sciences Business Overview
7.7.3 ATAI Life Sciences Psychedelic Medicine Major Product Offerings
7.7.4 ATAI Life Sciences Psychedelic Medicine Revenue in Global Market (2017-2022)
7.7.5 ATAI Life Sciences Key News
7.8 NUMINUS WELLNESS
7.8.1 NUMINUS WELLNESS Corporate Summary
7.8.2 NUMINUS WELLNESS Business Overview
7.8.3 NUMINUS WELLNESS Psychedelic Medicine Major Product Offerings
7.8.4 NUMINUS WELLNESS Psychedelic Medicine Revenue in Global Market (2017-2022)
7.8.5 NUMINUS WELLNESS Key News
7.9 MindMed
7.9.1 MindMed Corporate Summary
7.9.2 MindMed Business Overview
7.9.3 MindMed Psychedelic Medicine Major Product Offerings
7.9.4 MindMed Psychedelic Medicine Revenue in Global Market (2017-2022)
7.9.5 MindMed Key News
7.10 HAVN Life Sciences
7.10.1 HAVN Life Sciences Corporate Summary
7.10.2 HAVN Life Sciences Business Overview
7.10.3 HAVN Life Sciences Psychedelic Medicine Major Product Offerings
7.10.4 HAVN Life Sciences Psychedelic Medicine Revenue in Global Market (2017-2022)
7.10.5 HAVN Life Sciences Key News
7.11 Seelos Therapeutics
7.11.1 Seelos Therapeutics Corporate Summary
7.11.2 Seelos Therapeutics Business Overview
7.11.3 Seelos Therapeutics Psychedelic Medicine Major Product Offerings
7.11.4 Seelos Therapeutics Psychedelic Medicine Revenue in Global Market (2017-2022)
7.11.5 Seelos Therapeutics Key News
7.12 Jannsen
7.12.1 Jannsen Corporate Summary
7.12.2 Jannsen Business Overview
7.12.3 Jannsen Psychedelic Medicine Major Product Offerings
7.12.4 Jannsen Psychedelic Medicine Revenue in Global Market (2017-2022)
7.12.5 Jannsen Key News
7.13 Acadia Pharmaceuticals
7.13.1 Acadia Pharmaceuticals Corporate Summary
7.13.2 Acadia Pharmaceuticals Business Overview
7.13.3 Acadia Pharmaceuticals Psychedelic Medicine Major Product Offerings
7.13.4 Acadia Pharmaceuticals Psychedelic Medicine Revenue in Global Market (2017-2022)
7.13.5 Acadia Pharmaceuticals Key News
7.14 Intellipharmaceutics
7.14.1 Intellipharmaceutics Corporate Summary
7.14.2 Intellipharmaceutics Business Overview
7.14.3 Intellipharmaceutics Psychedelic Medicine Major Product Offerings
7.14.4 Intellipharmaceutics Psychedelic Medicine Revenue in Global Market (2017-2022)
7.14.5 Intellipharmaceutics Key News
7.15 Revive Therapeutics
7.15.1 Revive Therapeutics Corporate Summary
7.15.2 Revive Therapeutics Business Overview
7.15.3 Revive Therapeutics Psychedelic Medicine Major Product Offerings
7.15.4 Revive Therapeutics Psychedelic Medicine Revenue in Global Market (2017-2022)
7.15.5 Revive Therapeutics Key News
7.16 Mydecine Innovations Group
7.16.1 Mydecine Innovations Group Corporate Summary
7.16.2 Mydecine Innovations Group Business Overview
7.16.3 Mydecine Innovations Group Psychedelic Medicine Major Product Offerings
7.16.4 Mydecine Innovations Group Psychedelic Medicine Revenue in Global Market (2017-2022)
7.16.5 Mydecine Innovations Group Key News
7.17 Red Light Holland
7.17.1 Red Light Holland Corporate Summary
7.17.2 Red Light Holland Business Overview
7.17.3 Red Light Holland Psychedelic Medicine Major Product Offerings
7.17.4 Red Light Holland Psychedelic Medicine Revenue in Global Market (2017-2022)
7.17.5 Red Light Holland Key News
7.18 Braxia Scientific
7.18.1 Braxia Scientific Corporate Summary
7.18.2 Braxia Scientific Business Overview
7.18.3 Braxia Scientific Psychedelic Medicine Major Product Offerings
7.18.4 Braxia Scientific Psychedelic Medicine Revenue in Global Market (2017-2022)
7.18.5 Braxia Scientific Key News
7.19 Mind Cure Health
7.19.1 Mind Cure Health Corporate Summary
7.19.2 Mind Cure Health Business Overview
7.19.3 Mind Cure Health Psychedelic Medicine Major Product Offerings
7.19.4 Mind Cure Health Psychedelic Medicine Revenue in Global Market (2017-2022)
7.19.5 Mind Cure Health Key News
7.20 Entheon Biomedical
7.20.1 Entheon Biomedical Corporate Summary
7.20.2 Entheon Biomedical Business Overview
7.20.3 Entheon Biomedical Psychedelic Medicine Major Product Offerings
7.20.4 Entheon Biomedical Psychedelic Medicine Revenue in Global Market (2017-2022)
7.20.5 Entheon Biomedical Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
